Douglas Lewis
Neurology · Amarillo, TXNPI 1538166996
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $68,071 of the $96,806 with a category attached, or 70.3%. 27 manufacturers reported payments, led by Sanofi at 34.9% of the total. Among neurology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 424 payments — averaging $228.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$34K
- AbbVie$22K
- Teva Pharmaceuticals USA, Inc.$21K
- Amgen$11K
- Genentech USA, Inc.$7K
- Abbott$1K
- plus $2K from 21 others
What the payments were for
- Consulting fees$8,1658%
- Speaking & faculty fees$68,07170%
- Travel & lodging$14,73215%
- Food & beverage$5,7766%
- Education$620%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 63 | $33,758 |
| AbbVie(2 entities) | 42 | $21,511 |
| Teva Pharmaceuticals USA, Inc. | 76 | $20,716 |
| Amgen | 28 | $10,600 |
| Genentech USA, Inc. | 10 | $6,733 |
| Abbott | 8 | $1,402 |
| Neurocrine Biosciences, Inc. | 58 | $439 |
| Novartis | 18 | $310 |
| EMD Serono, Inc. | 19 | $270 |
| MDD US Operations, LLC | 13 | $186 |
| Avanir Pharmaceuticals, Inc. | 27 | $176 |
| Supernus Pharmaceuticals, Inc. | 13 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $131 |
| Livanova USA, Inc. | 2 | $107 |
| Sanofi-aventis U.S. LLC | 2 | $49 |
| Acadia Pharmaceuticals Inc | 3 | $40 |
| UCB, Inc. | 2 | $32 |
| Sunovion Pharmaceuticals Inc. | 2 | $29 |
| AstraZeneca | 2 | $28 |
| Acorda Therapeutics, Inc | 2 | $28 |
| Promius Pharma LLC | 1 | $17 |
| Grifols USA, LLC | 1 | $16 |
| Biogen | 1 | $14 |
| Incyte Corporation | 1 | $13 |
| Pfizer | 1 | $12 |
| SK Life Science, Inc. | 1 | $11 |
| Amneal Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$96,806 in reported general payments places this provider in the 90th percentile of 1,246 neurology providers in Texas.
Other neurology in Amarillo
- Sean MilliganAmarillo$580K
- Ann BassSan Antonio$1.7M
- William OndoHouston$1.4M
- Nirav PavasiaDallas$1.4M
- Mirla AvilaLubbock$1.3M
- Michael SoileauGeorgetown$1.2M
- Pankaj SatijaHouston$1.1M
- Annette HowardHouston$826K
- Benjamin GreenbergDallas$773K
- Annette OkaiPlano$730K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.